WARREN, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that it will report results for first quarter ended March 31, 2021 and provide an update on recent developments in its business after market close on Tuesday, May 4, 2021.

Read the original here:
Aquestive Therapeutics to Report First Quarter 2021 Financial Results and Recent Business Highlights on May 4 and Host Conference Call on May 5 at...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh